arrow
J

Joo Hyun Sohn

seoul national university (snu)
H指数:32
被引数:4,075

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Clinical Courses and Prognosis of Cirrhotic Patients after First Acute Decompensation: Prospective Cohort Study
2023-12-200
OAAI
Personalized Antiviral Drug Selection in Patients With Chronic Hepatitis B Using a Machine Learning Model: A Multinational Study
2023-03-073
PRE
Response-Guided Therapy With Cefotaxime, Ceftriaxone, or Ciprofloxacin for Spontaneous Bacterial Peritonitis: A Randomized Trial A Validation Study of 2021 AASLD Practice Guidance for SBP

头孢噻肟,头孢曲松或环丙沙星对自发性细菌性腹膜炎的反应指导治疗: 一项随机试验2021年AASLD SBP实践指南的验证研究

2023-01-037
PRE
Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B
2022-06-018
PRE
Effect of sarcopenia on survival in patients with cirrhosis: A meta-analysis
2022-03-01210
OA
An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B
2022-02-0163
PRE
Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial

继续马来酸贝西福韦酯与从富马酸替诺福韦酯转换治疗慢性乙型肝炎: 192周的3期试验结果

2021-04-0112
OAAI
Consensus recommendations of three-dimensional visualization for diagnosis and management of liver diseases

肝脏疾病诊断和管理的三维可视化共识建议

2020-07-07103
OAAI
Besifovir Dipivoxil Maleate 144-Week Treatment of Chronic Hepatitis B: An Open-Label Extensional Study of a Phase 3 Trial
2020-05-0114
OAAI
Efficacy and Safety of Besifovir Dipivoxil Maleate Compared With Tenofovir Disoproxil Fumarate in Treatment of Chronic Hepatitis B Virus Infection

马来酸贝替福韦酯与富马酸替诺福韦酯治疗慢性乙型肝炎病毒感染的疗效和安全性比较

2019-08-0139
OAAI